Literature DB >> 11880777

Histologic characterization of acute spinal cord injury treated with intravenous methylprednisolone.

A Merola1, Michael F O'Brien, B Andrew Castro, David A B Smith, James M Eule, Thomas G Lowe, Anthony P Dwyer, Thomas R Haher, N J Espat.   

Abstract

OBJECTIVE: Many substances have been investigated for attenuation of spinal cord injury after acute trauma; however, pharmacologically only steroid administration has shown clinical benefits. This study attempts to characterize local spinal cord histologic response to human dose equivalent (HDE) intravenous methylprednisolone (MP) administration in a rodent model of acute spinal cord injury.
DESIGN: Forty-eight Sprague-Dawley rats were divided equally into control and experimental groups. Each group was subdivided into eight sets of three animals each, according to postinjury intervals. Paraplegia after lower thoracic laminectomy was achieved using a standardized weight drop technique. INTERVENTION: Within one hour, experimental animals were treated with HDE MP followed by 23-hour continuous infusion of HDE MP. Spinal cords were harvested at variable intervals postinjury and prepared for histologic/immunohistochemistry examination. MAIN OUTCOME MEASUREMENTS: Edema, necrosis, and glial fibrillary acidic protein (GFAP) positivity in the specimens from treated/control groups were graded by microscopy and immunohistochemistry staining and compared in a blinded manner by a qualified neuropathologist and senior authors.
RESULTS: Minimal differences were observed between control and MP-treated animals at zero and four hours. At eight hours, increased white matter and medullary edema was evident in control versus MP-treated rats. This trend continued through twelve, sixteen, twenty-four, forty-eight, and seventy-two hours. No difference was observed in the astrocytic response to injury by GFAP immunohistochemistry between the groups.
CONCLUSIONS: Histologically, MP reduces the development of severe edema and preserves spinal cord architecture adjacent to the site of injury. In contrast, MP does not alter the development of spinal cord necrosis or astrocytic response at the zone of injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880777     DOI: 10.1097/00005131-200203000-00003

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  8 in total

1.  Neuroprotective effects of sildenafil in experimental spinal cord injury in rabbits.

Authors:  Hasan Kara; Selim Degirmenci; Ahmet Ak; Aysegul Bayir; Seyit Ali Kayis; Mehmet Uyar; Murat Akinci; Demet Acar; Metin Kocacan; Fikret Akyurek
Journal:  Bosn J Basic Med Sci       Date:  2015-01-08       Impact factor: 3.363

2.  Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

Authors:  Alfredo Gorio; Laura Madaschi; Barbara Di Stefano; Stephana Carelli; Anna Maria Di Giulio; Silvia De Biasi; Thomas Coleman; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

3.  Neuroprotective effects of methylprednisolone and hypothermia after experimental spinal cord injury: a histopathological and stereological study.

Authors:  Bunyami Unal; Suleyman Kaplan; Ersan Odaci; Huseyin Aslan; Selina Aksak; Deniz Unal; B Zuhal Altunkaynak; Cemal Gundogdu; Ahmet Gokyar
Journal:  Eurasian J Med       Date:  2009-12

4.  Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.

Authors:  J Marc Simard; Orest Tsymbalyuk; Alexander Ivanov; Svetlana Ivanova; Sergei Bhatta; Zhihua Geng; S Kyoon Woo; Volodymyr Gerzanich
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

5.  Flufenamic acid inhibits secondary hemorrhage and BSCB disruption after spinal cord injury.

Authors:  Yingtao Yao; Jianyi Xu; Tingting Yu; Zhilong Chen; Zhiyong Xiao; Jiedong Wang; Yiqiang Hu; Yongchao Wu; Dan Zhu
Journal:  Theranostics       Date:  2018-07-30       Impact factor: 11.556

6.  Effects of methylprednisolone and ganglioside GM-1 on a spinal lesion: a functional analysis.

Authors:  Márcio Oliveira Penna Carvalho; Tarcisio Eloy Pessoa de Barros Filho; Marcos Antonio Tebet
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

7.  Therapeutic strategy for acute spinal cord contusion injury: cell elimination combined with microsurgical intervention.

Authors:  Nurit Kalderon; Manickam Muruganandham; Jason A Koutcher; Melissa Potuzak
Journal:  PLoS One       Date:  2007-07-18       Impact factor: 3.240

8.  Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury.

Authors:  Shucui Jiang; Farid Bendjelloul; Patrizia Ballerini; Iolanda D'Alimonte; Elenora Nargi; Cai Jiang; Xinjie Huang; Michel P Rathbone
Journal:  Purinergic Signal       Date:  2007-09-25       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.